United KingdomStand No: 14.0H70
Accord Healthcare is present in over 45 European countries and over 85 markets around the world. Current portfolio includes over 500 INNs across Europe. Since 2008, the annual average growth has exceeded 54%. Further organic and inorganic growth is expected in Accord's pipeline counting with 700 INNs by 2021.
United KingdomStand No: 14.0H2
Protexin are dedicated to producing innovative research based products of the highest quality for animals and humans. Our belief is that nature is an ideal source of effective healthcare solutions, and that applied research and understanding can harness these solutions to the benefit of both humans and animals. We also know that too much refining of natural elements can reduce their effectiveness. That's why all products that carry the Protexin name are developed under our guiding philosophy – science and nature in balance. In practice this means that the natural healthcare and probiotic supplements we manufacture are extensively researched for safety and efficacy. We work closely with leading universities, hospitals and research centres around the world on a range of ongoing research programmes. We are always looking to improve our products, but never compromise on their natural basis.
South KoreaStand No: 12H52
AK & MN BioFarm is PMDA and Korean FDA approved Omega-3 API Manufacturer in the world. All the products from AK & MN Biofarm are produced under GMP and HACCP guide line. Our own technologies and the most advanced facilities allow AK & MN BioFarm to offer customers various EPA and/or DHA products from low concentration to over 99% purest products. Upon the customer requests, all formulation of Omega-3 is available from Food supplements to Active Pharmaceutical Ingredients.
NetherlandsStand No: 10F20
Aspen is a global supplier of branded and generic pharmaceutical products as well as infant nutritional and consumer healthcare products in selected territories. In line with the Group's commercial, production and territorial strategies, Aspen has identified thrombosis, anaesthetics, high potency & cytotoxics and infant nutritionals as four therapeutic categories which will get the highest focus based on materiality and future potential.The group has an extensive global presence with more than 10,000 employees. Aspen has a strong presence in both emerging and developed countries with more than ???????60 established business operations in approximately 50 countries. The Group supplies medicines and products to more than 150 countries. Aspen Oss B.V., established in 1923, is a leading global supplier of Active Pharmaceutical Ingredients (APIs) to the global pharmaceutical industry. Aspen Oss specializes in the manufacture of highly complex APIs and is dedicated to the production of high quality APIs. Our customers benefit from...
GermanyStand No: 10H6
AXXO is a leading international supplier with a rich product portfolio covering a wide range of therapeutic categories including active pharmaceutical ingredients (API), intermediates, finished dosage forms as well as the latest development in the field of biotech production i. e. monoclonal antibodies (MAB). Our international operating company would be pleased to offer you our custom-made services from developing, manufacturing and marketing APIs, finished dosage forms or registration dossiers to full health concepts like machinery & equipment for your own manufacturing. We are present in the EU, in a huge number of the CIS countries and in various South American and Middle East markets. Our product portfolio embraces APIs as well as finished formulations. Our dynamic and highly-motivated team is investigating, developing, producing and distributing innovative pharmaceutical products. We are offering just-in-time delivery, customized product parameters as well as registration assistance. Our expertise consists in the development and registration of...
SwitzerlandStand No: 8B20
Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership. Bachem. Pioneering Partner for Peptides
ChinaStand No: 14.0B26
A leading pharmaceutical company engaged in R&D, manufacturing and marketing of high quality medicinal products with special focus on CVS/CNS areas. Our manufacturing sites comply with EU/FDA GMP. Ginkgolide injection is a global innovative herbal medicinal product of its kind for treatment of mild-moderate cerebral infarction. Other generic products are Enoxaparin sodium injection, pantoprazole sodium for injection, etc. Over 20 generic drugs are under development. We also provide contract manufacture service of liquid injectables, lyophilized, tablets and capsules and cooperate with firms to introduce high-end pharmaceutical products into Chinese market.Baiyu are open to any business cooperation that can bring benefits to both sides.
SpainStand No: 14.0G40
BCN Peptides is focused on the GMP manufacture of synthetic peptides API's for pharmaceutical and veterinary application. We manufacture from R&D to commercial quantities of generic peptides and NCE's. Our state of the heart facility is fully GMP, US FDA and EMEA approved.
IndiaStand No: 10K11
BEC Chemicals specializes in manufacturing API's and Intermediates. We are WHO-GMP, EU-GMP, ISO 9001:2008, 14001:2004, 18001:2007 and OHSAS certified. We are 100% an export-oriented unit. Our manufacturing plant is at Roha (125kms from Mumbai), with dedicated blocks for each product. We manufacture APIs: Ketoprofen, Ketoprofen Lysinate, Dex-Ketoprofen Trometamol, Mesalamine/ Mesalazine. Our pipeline products are Hydroxytetrahydrofuran, Montelukast Sodium, Carbocisteine, Carbocisteine Lysinate. We have a Research and Development Center in Mumbai. BEC also has a state-of-the-art micronization unit at Mahape (near Mumbai).
IndiaStand No: 12J22
Biological E Limited established in 1953, leading manufacturer of Human vaccines Tetanus, DT, DTP, Td HepatitisB, DTP-HepB-Hib Pentavalent, Hib, IPV, Japanese encephalitis, Measles and Rubella, Tetanus Antitoxin and Snake Antivenin. Attained WHO prequalification for Tetanus, DTPHepBHib, JE, DTP and Td. APIs – Noscapine Base and HCL (Alkaloids) and Heparin Sodium. Pipeline Injectables - Heparin Inj, LMWH Enoxaparin, Dalteparin, Fosaprepitant, Daptomycin, Risperidone and Paliperidone Palmitate.
IndiaStand No: 6D40
Biophore, an established pharmaceutical company is engaged in the development and manufacture of niche pharmaceutical products for generic industry.Within a decade since inception in 2007, Biophore has emerged as a trusted partner in generic industry across US, Europe and other regulated markets. Biophore's product range is diverse and balanced with NCE, Branded products and grandfather products. Biophore's portfolio spread across 30 therapeutic segments, is specialized in development and manufacture of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media. For updated list of products, send an email to [email protected]
BrazilStand No: 14.1G71
Blau Farmacêutica, is a Brazilian multinational company and a pioneer in the development of recombinant proteins currently producing, bio-pharmaceuticals and Bio-similar selling in Brazil and several countries around the word. The hospital and pharmaceutical Blau line consists on an extensive and varied range of simple and complex products for treatment of several diseases, with 30 years of marketing focused in innovation and technology and with 5 subsidiaries at Latin America: Uruguay, Argentina, Colombia, Chile and Peru and soon will open one more subsidiary in Latin America.
South KoreaStand No: 12F49
BMI Korea, regardless of a short history from 2005 in Korean Pharmaceutical industry, has been rapidly growing & connecting into local, worldwide societies for “healthy life of human-being” with the industry's outstanding spotlight & concentration, which is derived from each BMI member's voluntary & creative R&D approach, non-stop challenge & passion, and young but most dynamical corporate's working environment for the future corporate's core value, to jump toward a global player. With a horizontal intergration of BMI's professional experiences, know-hows & novel technologies, BMI- Korea has been always putting all of effort, energy for development of differentiated & novel biopharmaceuticals & medical devices and beyond this, we - on behalf of all BMI members, promise to challenge our goal & dream to care for the best health of every human-being and to become a global leader in 21th century's healthcare industry.
TaiwanStand No: 6G30
Chirogate is a leading US-FDA inspected Prostaglandin (PG) manufacturer and owns more than 6 dedicated & cGMP-compliant production lines for cutting-edged manufacturing of PGs. Several process patents filed and granted worldwide are to provide a commercially revolutionary synthetic approach and an exciting spectrum of advanced intermediates for synthesis of new PG entities. US DMFs filed for Unoprostone Isopropyl, Treprostinil, Latanoprost, Bimatoprost, and Travoprost with additional registration experiences in China, Japan, Canada, Australia, New Zealand and major EU countries. Products: Unoprostone Isopropyl, Treprostinil, Treprostinil Sodium & Dienthanolamine, Beraprost Sodium, Carboprost Tromethamine, Iloprost Tromethamine, Latanoprostene Bunod, Latanoprost, Bimatoprost, Travoprost, Misoprostol, Lubiprostone, Epoprostenol Sodium, Dinoprostone, Tafluprost, Alprostadil, Dinoprost (& Tromethamine), and (+)-Cloprostenol (&Sodium).
SwitzerlandStand No: 9C50
Crystal Hemp is a Swiss Company that operates in the hemp sector and aims to produce and develop hemp extracts for every possible use through extensive investments in R&D. The Company is focusing on selling products to pharmaceutical, cosmeceutical and nutraceutical firms which are currently experiencing an increase in term of sales worldwide and operates in two different business fields: medical applications and hemp for industrial uses. Our business model is based on national and international supply chain of hemp from several selected farmers and international agreements for the extraction in a high-capacity plant (GMP certified facility) in order to offer the best products to the market. We will participate to the CPhI with our business partner Linnea SA.
BrazilStand No: 6F50
The right Partner in Brazil Since 2002 EcoTag represents manufacturers/exporters promoting our premium partner companies to a powerful range of buyers. We deal with API and Finished dosage for Pharmaceutical, Feed and Food industries. Our team is experienced and committed to create solutions leading to successful and pro?table long-term relationships.
South KoreaStand No: 12H44
Enzychem Lifesciences Corporation is a Global New Drug Development Company that was founded on the most advanced life sciences and technologies of medicinal chemistry in July 1999. With its Global New Drug R&D center in Seoul and two GMP manufacturing plants in Seoul Korea, it has since been developing and producing APIs and functional health foods, and developing global new drugs. We produce an extensive array of curative products and cosmetic ingredients. Our flagship APIs include D-Cycloserine and Terizidone, Contrast Agent(MRI/CT), antibiotics in the family of cephalosporin such as Cefbuperazone, Cefazedone and other APIs for anti-coagulant and anti-inflammatory analgesic drugs.
ItalyStand No: 12J10
ESSETI FARMACEUTICI is an Italian pharmaceutical company that from its beginning in 1956 has invested in the internationalization process anticipating times on competition, tracing new paths in the export of Italian production, a best banner in the world capable of transmitting and ensuring high quality standards and competitive prices in many markets. The products of our therapeutic areas combine top quality active ingredients made in Europe with innovative and excellence of the manufacturing process. The concept that characterizes the philosophy of our company is orientation to results, dynamism, innovation and attention to the international market.
South KoreaStand No: 12G46
EstechPharma Co., Ltd. manufactures and markets active pharmaceutical ingredients in South Korea. The company offers products under various categories, such as anti-inflammatory, analgesics, muscle relaxant, anti-septic, anti-spasmodics, anti-cataract, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, and anti-histamine, as well as products for the treatment of alcoholism, urinary incontinence, etc.
ItalyStand No: 10F43
FLAMMA is a family owned & run CMO, established in 1950. Based in the Bergamo area (near Milan in Northern Italy), Flamma is an award winning specialty pharmaceutical chemical manufacturer specialized in the cGMP manufacture of APIs, NCEs, RSMs, and advanced intermediates for the pharmaceutical industry. Flamma has particular expertise in high value chiral materials specifically functional amino acid related materials although Flamma is not limited by these chemistries. Flamma also manufactures specialty compounds and advanced intermediates for the nutraceutical and cosmetic industries and has several generic products available. Flamma prides itself in developing and producing compounds classified as APIs and/or finished products for its customers. FLAMMA has three cGMP manufacturing facilities. Both Italian locations (Chignolo & Isso) (capacities of 120 m3 and 130 m3, respectively) are regularly inspected by the FDA and AIFA (the Italian Ministry of Health). Flamma Honkai is located outside of Dalian, China (on the coast...
GermanyStand No: 5G30
Flavine has been working with advanced API manufacturers since 1975. Our offices are in the United States, Germany, Spain, France, China and India. We offer Active Pharmaceutical Ingredients, Fine Chemicals, Intermediates for API production and Pharmaceutical Finished Dosage Forms combined with Regulatory Affairs to support the marketing and sales in countries where USDMF, CEP and GMP certification is required.
ChinaStand No: 12A33
GeneScience Pharmaceuticals Co Ltd (GenSci) is one of the largest, most profitable and rapidly-growing biopharmaceutical companies in China, with 7 products on the market and over 10 products in the pipeline. GenSci's business is focused on developing, manufacturing and marketing biologics as well as innovative biogenerics. GenSci was awarded the first "Medical Center for Quality Controls of Genetic Engineering Pharmaceuticals" by Chinese Quality Association of Pharmaceuticals (CQAP) in 2007, and the first state genetic engineering "Enterprise's New Drug incubation base" & the state New Drug R&D Major Project of "Eleventh Five-Year Plan" in 2009. GenSci has achieved sustainable successes with rapid growth rates in the past twenty years. One of GenSci's important products, GenLei Jintropin (rhGH, Somatropin for Injection) has been the leading brand of rhGH in China with a dominant market share since launched in 1998.
LatviaStand No: 12F31
Grindeks is a vertically integrated pharmaceutical company from Latvia specializing in cardiovascular, CNS and anti-cancer products. Our portfolio of FDFs includes original products and generics. Currently Grindeks produces 24 APIs. Products are exported to 60 markets: of which EU, Japan, Russia and the USA are the main markets.
IndiaStand No: 8D41
Hemmo Pharmaceuticals is India's 1st and leading manufacturer of Peptides. Our team consists of more than 150 highly skilled, well trained employees including 3 PhDs, 30 Chemistry graduates and post graduates, 4 Engineers. At Hemmo Pharmaceuticals, GMPs are strictly enforced, right from selection of suppliers, origin and receipt of starting material and through the entire manufacturing process. Our modern & USFDA approvable facility offers capacity to manufacture peptide in kilo scale for solid and solution phase synthesis. We are approved by German Health Authorities. Our product list includes Oxytocin, Desmopressin, Leuprolide, Gonadorelin, Somatostatin, Octreotide, Terlipressin, Salmon Calcitonin, Tetracosactide, Buserelin. ?
South KoreaStand No: 12F65
Founded in 1941, Ildong Pharmaceutical Co Ltd has been contributing to healthier and happier lives of mankind for more than 75 years. We've been developing innovative products by utilizing knowledge, know-how that we have piled up. We mainly manufacture Anticancer, Probiotics, Sodium Hyaluronate and Antibiotics in our state-of-the art facility. - API - FDF Pharmaceutical ;Oncology ;GI, Cardiovascular, Antivital Agents, Endo, CNS, Anti-histamine, Respiratory, NSAIDS and Urogenital ; Antibiotics(Quinolones, Cepholosporins) ; Fixed Dose Combination(Cardiovascular) - Probiotics(Raw material)- Food supplement- Sodium Hyaluronate(Raw material, Fermal Filler)
South KoreaStand No: 12F61
Good ingredients make good medicine! INIST ST was founded as DONGWOO SYNTECH CO., LTD. in 2000 and ?has been a leader in medical supply ingredients and ingredient ?synthesizing technology development. Based on change, innovation and affection for life, INIST ST started the development of cerebrovascular medicine and has continued by researching and developing excellent quality generic ingredients and base change incrementally modified drugs and is supplying them locally and globally. Based on long-standing trust and skill, we develop not only multiple first generic ingredients, but also innovative new drugs such as heart disease contrast medium and a calcium blockade anti-cancer drug, and now our advanced technology surpasses the high barriers of the global market, and we are leading as a pioneer in the global market, such as exporting more than 15 billion KRW of products to Japan, a medically advanced country.
United KingdomStand No: 5A34
Established over 30 years ago, Klinge Chemicals Ltd leads the world in specialist potassium chloride production. The company's unique manufacturing process enables it to supply pharmaceutical, injectable and food grade potassium chloride products of the very highest quality. Superior standards of technical advice and customer service complete the Klinge Chemicals offering.
JapanStand No: 7A61
Koa Shoji Co Ltd has been leading generic pharmaceuticals business in Japan as an importer of active pharmaceutical ingredients and intermediates. We have been devoting ourselves to pursue strict quality standard to satisfy our Japanese customers. For foreign API suppliers, we support them as a DMF in-country caretaker and assist their accreditation in Japan. We also update the information about Japanese API market with our own research.
TaiwanStand No: 14.1H93
KriSan Biotech was founded in August, 2015 and are located in Tainan Science Park. KriSan has 60 personnel, including 8 Ph.D., and 30 master, whose average industry experiences are 10+ years. KriSan specializes in process and analytical R&D and the production of CGMP Active Pharmaceutical Ingredients (APIs).KriSan targets two market segments in the global pharmaceutical industry: 1. Customized CRO/CDMO/CMO services: including the supply of gram to kilogram quantities of small molecule, peptide, and peptide-drug conjugations (PDCs) from pre-clinical through phase 2 stages, and CMC activities containing regulation consultation.2. Generic API manufacturing: mainly focus on the Japanese market with products provided years before originator/brand patents expire. Processes are guaranteed to be non-infringing, and products are supplied at price-competitive levels.
GreeceStand No: 9A60
LABOCHEM SA has been established in 1990 as an agency and distribution company of APIs and excipients for the pharmaceutical, cosmetic and chemical industry, with headquarters in Athens, Greece. Our business activities have expanded all over the world in EU and CIS countries. Labochem develops generic products/dossiers available for exports and license out. We are also agents of machinery (processing and packaging) for the pharma, chemical, cosmetic, personal care and food industries.
IndiaStand No: 14.1F70
5th ranked Indian Pharmaceutical Company, having own R&D, BE Centre, API, Finished Dosage manufacturing sites, approved by USFDA,MHRA etc. Have CVS/CNS/Anti-Diabetic/Anti-HIV/AntiTB/Anti Asthmatic/Anti Malarial products with presence across 110 countries and subsidiaries in USA, UK, Spain, South Africa, Ukraine and Kazak. We offer: MA of EU,Out-licensing US/EUCTD with FDF/API Supply.
IndiaStand No: 7C60
Morepen Laboratories Limited is a 33 year old company manufacturing APIs (Loratadine, Desloratadine, Atorvastatin, Montelukast, Rosuvastatin, Fexofenadine, Olmesartan, Sitagliptin Linagliptin, Saxagliptin, Dapagliflozin, Canagliflozin etc.) at its world class manufacturing facilities, approved by USFDA, European & other regulatory authorities. Morepen adheres to latest cGMP standards, has DMF/CoS/Tech.Packs, exports to more than 60 countries.
United Arab EmiratesStand No: 12F42
Neopharma, UAE's premier pharmaceutical manufacturing company commenced operations in 2003 with the vision to locally manufacture world class pharmaceuticals at affordable prices. From a single manufacturing unit, Neopharma today has become a global pharmaceutical company supported by 5 manufacturing facilities spread across 3 continents delivering branded and generic formulations, and active pharmaceutical ingredients (APIs). The product portfolio covers 100 high-quality molecules in 9 therapy areas including anti-infectives, neurology, cardiology, orthopedics, diabetology, gastroenterology, urology, dermatology, gynecology, respiratory, dental and nutritionals. Driven by innovation, Neopharma lays strong emphasis on research, especially towards development of processes and products that are patent non-infringing. Neopharma currently caters to over 50 international markets including Middle East, Africa, CIS, USA and South East Asia. For further information, please visit www.neopharma.com
ItalyStand No: 8H20
Newchem is an Italian company, established in 1998. Newchem, with Manufacturing facilities in Verona and San Martino Siccomario (Pavia) and Headquarter in Milano, manufactures a wide range of active pharmaceutical ingredients (API), in particular Steroids, Hormones and Prostaglandins, according to the strictest quality specifications. Newchem is active in the worldwide markets with its own know-how, and is intended to be an efficient, reliable and competitive supplier.
LatviaStand No: 12H10
JSC Olainfarm is the leading manufacturer in the chemical and pharmaceutical sector of the Baltic States with more than 40 years of experience. Olainfarm manufactures more than 60 FDFs in various forms (tablets, film-coated tablets, sugar-coated tablets, capsules, hard shell, powders in sachets for internal and external use). The key areas of specialization in FDFs include neurology (cholinesterase inhibitors, anxiolytics, psychostimulants, nootropics), cardiology (antiarrhytmics, energy metabolism enhancers), infectology (original nitrofurantoine derivatives and antivirals) and allergology (non-sedative, fast acting antihistamines). The company produces 25 different APIs authorized by the competent authorities and more than 20 Intermediates and chemical compounds. Olainfarm has a long-standing technological and know-how advantage in adamantane chemistry, quinuclidine chemistry, furan chemistry and optically pure ? -aminobutyric acid derivatives, as well as in chiral compounds. Olainfarm's facilities complies with the strictest quality standards and are regularly inspected by the most important Authorities, including US FDA. Company exports to more than 60 global markets.
Hong Kong S.A.R., ChinaStand No: 8A31
Pen Tsao Chemical Industry Ltd produce in its Shanghai plant a range of API's and advanced pharma intermediates for domestic and International markets. The highly flexible multi-purpose production facilities focusing on development and production of Niche API's. The plant, under German management, is fully cGMP certified by National and International authorities. We are leader in MDR and XDR Tuberculosis WHO prequalified APIs.
JapanStand No: 9H70
PeptiStar is a CDMO (Contract Development and Manufacturing Organization) for Peptide APIs (Active Pharmaceutical Ingredients), from traditional peptides to constrained peptides which are generally macrocyclic and stapled peptides including non-natural amino acids. PeptiStar is a fully technology-based company and provide you with highly value added services through the innovative manufacturing technologies.
GermanyStand No: 14.0C10
Pharma-Zentrale GmbH, located in Germany, is a GMP-certified pharmaceutical manufacturer with Manufacturers Authorization. Pharma-Zentrale GmbH is a specialist in probiotics (LBP - live biotherapeutic products and phytopharmaceutical products. Among other probiotic products like e.g. saccharomyces boulardii and lactobacillus acidophilus, we are producing the worldwide unique probiotic Mutaflor® with the API: E. Coli Nissle 1917. We are offering full service for production and packaging of liquids, capsules and tablets. Licensing and distribution is also available.
FranceStand No: 10D110
PMC Isochem offers contract research, custom manufacturing and catalogue products for Pharmaceutical companies worldwide. Our offer addresses three areas: CDMO services: GMP industrial exclusive custom synthesis and provides tailor made services from development to production, including route selection. 3 FDA audited manufacturing plants Drug delivery solutions: TPGS-1000 NF USP for poorly soluble drug formulation and Polypeptides based solution for Nano Encapsulation and Polymer Drug Conjugates Generic APIs: 20 generic API for US, EU and worldwide market
PolandStand No: 14.1A12
Polfa Tarchomin SA, is one of the most experienced pharmaceutical companies in the world, which history dates back to 1823. Our primary goal is to improve the quality of our patients' lives. Due to this fact we develop the best – from the patients' point of view – products and services. We care for those products to be available for the people, who need them. Polfa Tarchomin is a leader in the anti-infectives market. The company also holds an significant market position in the category of insulin, psychotropic drugs and dermatological preparations. Polfa Tarchomin S.A in total provides over a hundred medicinal products. All of them are available in a range of forms and sizes in order to ensure optimal medical treatment and minimal side effects experienced by the patient. Polfa Tarchomin S.A. specialises in the prescription drugs. The production line of oral penicillin forms, aerosol filling and freeze-drying techniques...
IndiaStand No: 7A2
Founded in 1988, WHO GMP, Written Confirmation,ISO9001:2015 certified company engaged in the manufacturing of APIs having state-of-the -art-facility. Our products include APIs, Vitamins, Iodine compounds & Veterinary products namely Thiamine Hydrochloride/Mononirate(Vit.B1), Riboflavin (Vit.B2), Riboflavin Sodium Phosphate, Folic Acid (Vit.B9), Benfotiamine, Povidone Iodine 30/06 Stability grade, Potassium Iodide, Sodium Iodide, Potassium Iodate, Iodoform, Rafoxanide, Closantel, Dithranol, Luliconazole & Cetirizine Hydrochloride. Exporting to over 40 countries, we can provide DMF/EDMF/CTD for our products. We can also undertake contract manufacturing.
SpainStand No: 14.0J70
Founded in 1929, Reig Jofre is #5 Spanish pharmaceutical company by turnover that trades on the Spanish stock exchange under the ticker RJF. It is devoted to the research, development, manufacture and marketing of pharmaceutical products and nutritional supplements, as well as on specialized contract development and manufacturing. The company directs its activity in two business units: • technological specialization area (49.7% of total sales) in the development and manufacture of antibiotics derived from penicillin and sterile injectable products, which made possible to grow internationally and distribute or license Reig Jofre products in more than 65 countries on five continents. • therapeutic areas and health care (50.3% of sales) focused on the research, development, manufacture and marketing of our own developments in dermatology and gynecology, mainly, and in the development of OTCs products in the field of ENT and topical disinfectants. This area also includes the line of nutritional supplements,...
South KoreaStand No: 12G52
Samyang has been developing and marketing novel DDS and medical devices. Samyang recently becomes a fully integrated company with R&D, GMP facility for APIs and FDFs (injections, patches). Samyang has been expanding its relationship with partners and is looking to find potential companies that would create a good synergy.
FranceStand No: 6B61
Sanofi, a global life sciences company Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients' daily life, wherever they live and enable them to enjoy a healthier life.
TaiwanStand No: 6B42
ScinoPharm Taiwan Ltd is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a wide portfolio of services ranging from custom synthesis for early phase pharmaceutical activities to brand companies as well as APIs for the generic industry. Combining cost-effective resources and productivity of Asia along with unmatched regulatory know-how, ScinoPharm is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector.
South KoreaStand No: 12G40
Shin Poong Pharm. Co., Ltd is a R&D oriented multinational pharmaceutical company headquartered in Seoul, South Korea, with 7 manufacturing site worldwide with global partners in over 59 countries. Main Focusing Area Cardiovascular CNS Surgical Woundcare Musculoskeletal Anti-infective Product List R&D Pipeline [Marketed] Medicurtain Inj.: Surgical adhesion barrier (Medical device with novel mode of action) Pyramax Tab.: FDC/Malaria (NCE) Pyramax Granule: FDC/Pediatric malaria (NCE) CandeAmlo Tab.: FDC/hypertension (IMD) EzeRosu Tab.: FDC/hyperlipidemia (IMD) [Phase III-IV] Pyramax Tab.: FDC/Malaria (NCE) Pyramax Granule: FDC/Pediatric malaria (NCE) [Phase II] SP-8203: Acute ischemic stroke (NCE) [Phase I] SP-35454: Osteoporosis/fracture healing (NCE) HyalOne™: Osteoarthritis (NME) [Preclinical] SP-8008: Anti-platelet (NCE) SP-8232: Heart failure (NCE) SP-8356: Atherosclerosis (NCE) FreeWink™: Dermal/body filler (NME) Platform Technology Products Hyal Forte Inj. (Pre-filled) - Sodium hyaluronate 20mg/2mL - Viscosupplement for 3 time treatment (Osteoarthritis) - No.1 Sales in Korea Clamoxin Dispersible Tab. 250mg for syrup - Amoxillin sodium 200mg/Potassium clavulanate 50mg -...
IndiaStand No: 8C41
We , SHREEJI PHARMA International ( ISO & DUNS No certified company ), established in 2004, are proud to introduce ourselves as one of the leading Merchants exporters AND GLOBAL SOURCING COMPANY in India in the field of Active Pharma Ingredients, Chemicals, Pharmaceuticals Raw Materials, Nutraceuticals ,herbals, Phytochemicals & Intermediates. We thus, mainly focus on the exports of the APIs with high levels of integrity, respect & recognition. We are one of Leading exporters of Microcrystalline Cellulose ( Avicel), Sodium starch Glycolate ( SSG) & Croscarmellose Sodium - all grade with US DMF , US FDA Reg.No. , GMP , ISO , Kosher , Halal , IPEC
IndiaStand No: 8C32
SM Herbals is a 24-year-old company with a group turnover of over USD100 Million. We extract and isolate phytochemicals from plants. We have four dedicated GMP approved production units that isolate pure molecules of 10 DAB III, Camptothecin, Quinine Sulphate and Thiocolchicoside. We also have a DMF filed with the USFDA for our major products. We have vendor approvals from leading pharmaceutical companies and also have our own plantation to secure key raw materials. Our extraction process allows us to be leading manufacturers in the Nutraceuticals, dietary supplements, Cosmeceuticals, APIs, Alkaloids and other categories. We are an established name in the phytoceutical industry – internationally as well as within our country.
FranceStand No: 8F20
Socosur Chem is a distribution company focused on Active Pharmaceutical Ingredients, especially in Antibiotics, Cardiology, Ophtalmic and Oncology therapeutics. It was established in 1990 with a mission to be a reference European importation and distribution company as confirmed again with the successful 2015 GDP ANSM inspection. Solution provider for Biotech companies looking to industrialize their Active Pharmaceutical Ingredients. Distribution and agency activities for peptides and fine chemicals producers for pharmaceutical and veterinary use over the European markets. European regulatory filings development and marketing support services.
GermanyStand No: 10A30
German based SRL Pharma (former BK Giulini GmbH) is a leading manufacturer of antacid compounds offering the widest range of products available from one supplier. SRL Pharma GmbH's manufacturing facilities operate to the highest standards under a total Quality concept which is an integral part of the company's philosophy. Our product portfolio covers a broad variety of Aluminium and Magnesium Hydroxides, Magaldrate, Hydrotalcite, Amalgate, Dihydroxy Aluminium Sodium Carbonate (DASC), Aluminium Phospate and Sucralfate as powders and suspensions. Customer-tailored products are available on request. Our antacid production facility is a GMP, FDA and ISO 9001, ISO 14001, BH OHSAS 18001 certified plant and is licensed to manufacture bulk antacid formulations to §13 of the German Drug Law.
SwitzerlandStand No: 6A11
STRAGEN is a global Health Care Company based in Geneva, Switzerland, focused on the development of niche generic pharmaceuticals, consumer health products, and drug development programmes. STRAGEN continues to grow by developing new products and expanding its international presence through a network of partners, exclusive distributors, and new affiliate offices.
SpainStand No: 8B70
SUANFARMA Group was born in Spain in 1993 and is specialized in the development, production and marketing of raw materials and finished dosage forms for the pharmaceutical, biotechnological, veterinary, nutritional and cosmetic sectors. International expansion began immediately following the creation of SUANFARMA, so that by 1994 the first commercial office abroad was opened in China. Subsequently, other international subsidiaries were established in different countries. Currently, Suanfarma´s international activities extend to more than 60 countries on all 5 continents. Through a powerful worldwide network we can provide high quality solutions for each individual client's needs.
TaiwanStand No: 9A70
Taiwan Pharmaceutical Alliance (TPA) comprises several Taiwan-based manufacturers, including API & FDF (chemicals & biologics). TPA facilities pass PIC/S GMP. Products are marketed in US, EU, Japan & ASEAN etc. TPA provides quality products with affordable price. Niche products include liposome & microsphere, OROS Tablets/ ODT, high potent soft gel, MDI/DPI, eye drops, patch, biosimilar etc. Services include CDMO/CMO, license in/out, and trading etc. TPA is your trustworthy partner in the dynamic markets.
United StatesStand No: 7H60SSP
Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method development. Tecoland provides high quality APIs to the pharmaceutical industry, with reliable technical and regulatory support such as USDMF, CEP, EDMF that are critical to the speedy approval of our customers' regulatory filings.
GreeceStand No: 1D50
Vioser S.A. is a dynamic and constantly expanding Greek pharmaceutical industry, established in 1984 in Trikala, Greece.Working strictly under the GMP regulations we can assure high quality, safety and reliability for our products and services. Our portfolio includes pharmaceutical I.V. solutions, generic antibiotics and CE marked irrigation solutions, bottled in polyethylene containers, produced with the Blow/Fill/Seal Technology®.
IsraelStand No: 7H50
Wavelength Pharmaceuticals is the indpendent API company of choice for pharmaceutical industry leaders that require advanced API solutions to gain sustainable, competitive advantages. We are on the same wavelength. A partner in tune with the results required to better support your needs. Founded in Israel in 1987, having more than 250 customers in 50 countries, Wavelength employs a highly skilled team with all the expertise you require to advance your products to market, now, and well into the future. Our cGMP-compliant facility is a first-class operation recognized for excellence in safety, and environmental stewardship having more than 30 years of exceptional regulatory track record with leading global regulatory authorities such as USFDA, EU-EMA, PMDA, TGA, KFDA, ANVISA and COFEPRIS. We are experts in complex chemistry, innovative process development, crystalline forms and particle design and we offer customized solutions to meet individual customer requirements including creative business models, co-development partnerships and...
DenmarkStand No: 14.0G10
Xellia is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Our anti-infective treatments combat serious bacterial and antibiotic resistant infections as well as certain fungal diseases. Xellia is wholly owned by Novo Holdings A/S. Production Sites: Five state-of-the-art manufacturing facilities located in; Denmark, Hungary, China and in the U.S.Expertise: Xellia has over 100 years' experience in the development, manufacture and supply of fermented and semi-synthetic Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). Xellia is the leading supplier of the important anti-infectives Vancomycin and Colistimethate Sodium (CMS).
ChinaStand No: 6F17
Zhejiang Ausun Pharmaceutical Co Ltd, established in 2009 and covering an area of 70,000 square meters, is located in Zhejiang Chemical Materials Base, Linhai Zone. Ausun Pharma specializes in the development and manufacturing of formulations, APIs, pharmaceutical intermediates and fine chemicals,and plans to develop special varieties of medical products with high added-value, low energy consumption, low pollution and own intellectual property rights according to the market need. Honesty & win-win is our basic principle. Ausun Pharm. is your reliable Strategic Partner!
ChinaStand No: 7B20
Zhejiang Hisun Pharmaceutical Co., Ltd. located in Taizhou, Zhejiang Province, a coastal city in southeastern China, was founded in 1956. In year 2000, Hisun was listed as a public company in Shanghai A share Stock Exchange. Today, Hisun is one of the biggest manufacturing bases of antibiotic oncology products, and has become one of leading pharmaceutical manufacturers in China.